Chemical Compound

nateglinide

CAS Registry Number 105816-04-4

Back to search Request a Quote

Primary Record

nateglinide

In stock: 8,289 g
Purity: 98.9 %
CAS: 105816-04-4

Compound Identifiers & Properties

CAS: 105816-04-4
PubChem CID: 5311309
SMILES: CC(C)C1CCC(CC1)C(=O)N[C@H](CC2=CC=CC=C2)C(=O)O
Canonical SMILES: CC(C)C1CCC(C(=O)N[C@H](Cc2ccccc2)C(=O)O)CC1

Names & Synonyms

nateglinide
Starlix
Starsis
senaglinide
Fastic
Trazec
105816-04-4
D-Nateglinide
nateglinida
Nateglinide [INN]
glinate
glunate
nateglinidum
natelide
nate-glinide
ent-Nateglinide
Nateglinide RS
SDZ-DJN-608
Nateglinide CRS
Starlix;
Fastic;
Nateglinide EP impurity C
Starlix (TN)
Starsis (TN)
Nateglinide, Starlix
IPCCPA
AY-4166
DJN-608
Nateglinide (Starlix)
Nateglinide impurity C
AC1NSKEK
Nateglinide (Standard)
XTM4DQP5S5
DJN 608
CHEMBL783
Nateglinide cis Impurity
SDZ DJN 608
SDZ-DJN 608
A-4166
NATEGLINIDE [MI]
UNII-XTM4DQP5S5
NATEGLINIDE [JAN]
UNII-41X3PWK4O2
(1s,4S)-D-Nateglinide
NATEGLINIDE [USAN]
D06PSS
NATEGLINIDE [VANDF]
Nateglinide impurity C CRS
41X3PWK4O2
A1L9H
NATEGLINIDE [MART.]
105816-06-6
SCHEMBL22088
DTXSID9040687
NATEGLINIDE [USP-RS]
NATEGLINIDE [WHO-DD]
Nateglinide impurity C [EP]
Novartis brand of nateglinide
C19H27NO3
MLS000759500
MLS001424043
MLS003915639
MLS006011429
nateglinide, (D-Phe)-isomer
BIDD:GT0257
Nateglinide cis-isomer [USP]
SCHEMBL303827
AY 4166
AY4166
MFCD00875706
NATEGLINIDE [EMA EPAR]
Nateglinide Related CoMpound C
GTPL6833
orb1307803
SCHEMBL9232138
ZINC9689
Nateglinide (JP18/USP/INN)
CHEMBL2114389
DTXCID7020687
Nateglinide [USAN:USP:INN:BAN]
CHEBI:31897
CHEBI:94617
HY-B0422R
MSK7194
NATEGLINIDE [ORANGE BOOK]
nateglinide, (cis,D-Phe)-isomer
OELFLUMRDSZNSF-BRWVUGGUSA-N
YM-026
GLXC-07314
HMS2051G20
HMS2089A10
HMS2235O08
HMS3675G17
HMS3715F12
NATEGLINIDE [EP MONOGRAPH]
NATEGLINIDE [USP MONOGRAPH]
NSC-758695
BCP28400
EBD10749
HY-B0422
Tox21_111432
A 4166
BBL033469
BDBM50344967
C19-H27-N-O3
EBC-11228
EBC-12167
s2489
STK647123
Nateglinide related compound C [USP]
AKOS005577723
AKOS015841612
AKOS015960899
Nateglinide, >=98% (HPLC), solid
Tox21_111432_1
ZINC100015346
ZINC101489663
AC-1690
CB11566
CCG-100898
CID5311309
CS-2528
CS-O-30674
DB00731
FN26165
KS-5143
NC00148
NSC 758695
NCGC00095121-01
NCGC00095121-12
NCGC00095121-16
NCGC00178741-03
NCGC00271534-02
NCGC00271534-03
BC204579
CPD000466372
SAM001246721
SMR000466372
AB0011153
AB2000594
J259.863I
n-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-d-phenylalanine
TL8000218
(2R)-3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid
A4166
B2198
CAS-105816-04-4
N0912
NATEGLINIDE CIS-ISOMER [USP IMPURITY]
NATEGLINIDE IMPURITY C [EP IMPURITY]
NS00000602
NS00073312
SW197528-2
J1.887.176I
(r)-2-((1r,4r)-4-isopropylcyclohexanecarboxamido)-3-phenylpropanoic acid
A10629
C12508
D01111
EN300-303645
K-0514
N-[(trans-4-Isopropylcyclohexyl)carbonyl]-D-phenylalanine
(-)-N-(trans-4-Isopropylcyclohexanecarbonyl)-D-phenylalanine
AB00639979-06
AB00639979-08
AB00639979-09
AB00639979-11
AB00639979_12
N-((4-isopropylcyclohexyl)carbonyl)phenylalanine
816N044
A-4166;
EN300-27126236
N-((cis-4-Isopropylcyclohexyl)carbonyl)-D-phenylalanine
N-(Trans-4-Isopropylcyclohexylcarbonyl)-D-Phenyl Alanine
(2R)-3-phenyl-2-{[(1r,4r)-4-(propan-2-yl)cyclohexyl]formamido}propanoic acid
105746-37-0
A1-02996
D-Phenylalanine, N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-, cis-
D-Phenylalanine, N-[[trans-4-(1-methylethyl)cyclohexyl]carbonyl]-
N-[(trans-4-isopropylcyclohexyl)-carbonyl]-D-phenylalanine
Q2254797
BRD-K44353683-001-07-5
BRD-K44353683-001-08-3
N-[[cis-4-(1-Methylethyl)cyclohexyl]carbonyl]-D-phenylalanine(Nateglinide Impurity)
n-{[4-(propan-2-yl)cyclohexyl]carbonyl}phenylalanine
NATEGLINIDE RELATED COMPOUND C [USP IMPURITY]
Q27166439
D-Phenylalanine, N-((cis-4-(1-methylethyl)cyclohexyl)carbonyl)-
N-((cis-4-(1-Methylethyl)cyclohexyl)carbonyl)-D-phenylalanine
n-(trans-4-isopropylcyclohexylcarbonyl)-d-phenylalanine
N-{[trans-4-(propan-2-yl)cyclohexyl]carbonyl}-D-phenylalanine
trans-N-((4-(1-Methylethyl)cyclohexyl)carbonyl)-D-phenylalanine
Z1514053266
(R)-2-(cis-4-Isopropylcyclohexanecarboxamido)-3-phenylpropanoic acid
D-Phenylalanine, N-((4-(1-methylethyl)cyclohexyl)carbonyl)-, cis-
D-phenylalanine, N-((trans-4-(1-methylethyl)cyclohexyl)carbonyl)-
N-[[4-(1-methylethyl)cyclohexyl]carbonyl]-D-phenylalanine
Nateglinide, European Pharmacopoeia (EP) Reference Standard
((1r,4R)-4-isopropylcyclohexane-1-carbonyl)-D-phenylalanine
(-)-n-(trans-4-isopropylcyclohexyl-1-carbonyl)-d-phenylalanine
(2R)-2-[(4-isopropylcyclohexanecarbonyl)amino]-3-phenyl-propanoic acid
(2R)-2-[[oxo-(4-propan-2-ylcyclohexyl)methyl]amino]-3-phenylpropanoic acid
(R)-2-rel-((1r,4R)-4-Isopropylcyclohexanecarboxamido)-3-phenylpropanoic acid
N-(4alpha-Isopropylcyclohexan-1beta-yl)carbonyl-D-phenylalanine
n-(trans-4-Isopropylcylolohexylcarboxyl)-d-phenylpropylicacid
2-[(4-Isopropyl-cyclohexanecarbonyl)-amino]-3-phenyl-propionic acid
3-phenyl-2-[(4-propan-2-ylcyclohexanecarbonyl)amino]propanoic acid
N-(4alpha-Isopropylcyclohexan-1alpha-yl)carbonyl-D-phenylalanine
N-(4alpha-Isopropylcyclohexan-1alpha-ylcarbonyl)-D-phenylalanine
N-[(1r,4R)-4-(Propan-2-yl)cyclohexane-1-carbonyl]-D-phenylalanine
N-[(4beta-Isopropylcyclohexan-1alpha-yl)carbonyl]-D-phenylalanine
N-[(4beta-Isopropylcyclohexan-1beta-yl)carbonyl]-D-phenylalanine
N-[[(1beta)-4alpha-Isopropylcyclohexyl]carbonyl]-D-phenylalanine
Nateglinide, United States Pharmacopeia (USP) Reference Standard
trans-N-{[4-(1-methylethyl)cyclohexyl]carbonyl}-D-phenylalanine
(2R)-3-phenyl-2-{[4-(propan-2-yl)cyclohexyl]formamido}propanoic acid
(R)-2-((1s,4S)-4-isopropylcyclohexanecarboxamido)-3-phenylpropanoic acid
{N}-[({TRANS}-4-ISOPROPYLCYCLOHEXYL)CARBONYL]-D-PHENYLALANINE
D-Phenylalanine, N-((4-(1-methylethyl)cyclohexyl)carbonyl)-, trans-
N-[[4alpha-(1-Methylethyl)cyclohexan-1beta-yl]carbonyl]-D-phenylalanine
N-[[4beta-(1-Methylethyl)cyclohexan-1alpha-yl]carbonyl]-D-phenylalanine
(2R)-3-phenyl-2-{[(1s,4s)-4-(propan-2-yl)cyclohexyl]formamido}propanoic acid
(R)-2-rel-((1r,4R)-4-Isopropylcyclohexanecarboxamido)-3-phenylpropanoicacid
N-[[cis-4-(1-Methylethyl)cyclohexyl]carbonyl]-D-phenylalanine (Nateglinide Impurity)